These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2295077

  • 1. Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats.
    Debs RJ, Fuchs HJ, Philip R, Brunette EN, Düzgüneş N, Shellito JE, Liggitt D, Patton JR.
    Cancer Res; 1990 Jan 15; 50(2):375-80. PubMed ID: 2295077
    [Abstract] [Full Text] [Related]

  • 2. Recombinant tumor necrosis factor alpha inhibits growth of methylcholanthrene-induced sarcoma and enhances natural killer activity of tumor-infiltrating lymphocytes in aging rats.
    Ziółkowska M, Nowak JJ, Janiak M, Ryzewska A.
    Arch Immunol Ther Exp (Warsz); 1993 Jan 15; 41(5-6):357-64. PubMed ID: 8010877
    [Abstract] [Full Text] [Related]

  • 3. Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats.
    Debs RJ, Fuchs HJ, Philip R, Montgomery AB, Brunette EN, Liggitt D, Patton JS, Shellito JE.
    J Immunol; 1988 May 15; 140(10):3482-8. PubMed ID: 3283235
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
    Palladino MA, Shalaby MR, Kramer SM, Ferraiolo BL, Baughman RA, Deleo AB, Crase D, Marafino B, Aggarwal BB, Figari IS.
    J Immunol; 1987 Jun 01; 138(11):4023-32. PubMed ID: 3295044
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of recombinant human tumor necrosis factor-alpha in rats. Effects of size and number of doses and nephrectomy.
    Ferraiolo BL, McCabe J, Hollenbach S, Hultgren B, Pitti R, Wilking H.
    Drug Metab Dispos; 1989 Jun 01; 17(4):369-72. PubMed ID: 2571474
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma.
    Lu L, Srour EF, Warren DJ, Walker D, Graham CD, Walker EB, Jansen J, Broxmeyer HE.
    J Immunol; 1988 Jul 01; 141(1):201-7. PubMed ID: 2454257
    [Abstract] [Full Text] [Related]

  • 7. Liposome-associated tumor necrosis factor retains bioactivity in the presence of neutralizing anti-tumor necrosis factor antibodies.
    Debs RJ, Düzgüneş N, Brunette EN, Fendly B, Patton J, Philip R.
    J Immunol; 1989 Aug 15; 143(4):1192-7. PubMed ID: 2787358
    [Abstract] [Full Text] [Related]

  • 8. Modulation of innate immunological factors by STEALTH liposome-encapsulated tumor necrosis factor-alpha in a colon tumor xenograft model.
    Kim DW, Andres ML, Kajioka EH, Dutta-Roy R, Miller GM, Seynhaeve AL, ten Hagen TL, Gridley DS.
    Anticancer Res; 2002 Aug 15; 22(2A):777-88. PubMed ID: 12014650
    [Abstract] [Full Text] [Related]

  • 9. Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice.
    Postma NS, Crommelin DJ, Eling WM, Zuidema J.
    J Pharmacol Exp Ther; 1999 Jan 15; 288(1):114-20. PubMed ID: 9862761
    [Abstract] [Full Text] [Related]

  • 10. Immunohistological analysis of immune cell infiltration of a human colon tumor xenograft after treatment with Stealth liposome-encapsulated tumor necrosis factor-alpha and radiation.
    Kim DW, Andres ML, Miller GM, Cao JD, Green LM, Seynhaeve AL, Ten Hagen TL, Gridley DS.
    Int J Oncol; 2002 Nov 15; 21(5):973-9. PubMed ID: 12370743
    [Abstract] [Full Text] [Related]

  • 11. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
    Gridley DS, Slater JM, Stickney DR.
    J Biol Response Mod; 1989 Dec 15; 8(6):593-602. PubMed ID: 2513378
    [Abstract] [Full Text] [Related]

  • 12. PEGylated recombinant human tumor necrosis factor alpha: preparation and anti-tumor potency.
    Li YP, Pei YY, Ding J, Shen ZM, Zhang XY, Gu ZH, Zhou JJ.
    Acta Pharmacol Sin; 2001 Jun 15; 22(6):549-55. PubMed ID: 11747763
    [Abstract] [Full Text] [Related]

  • 13. Effects of growth factors on the antiproliferative activity of tumor necrosis factors.
    Sugarman BJ, Lewis GD, Eessalu TE, Aggarwal BB, Shepard HM.
    Cancer Res; 1987 Feb 01; 47(3):780-6. PubMed ID: 3802082
    [Abstract] [Full Text] [Related]

  • 14. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G, Kirsh R, Fogler WE, Fidler IJ.
    Cancer Res; 1979 Mar 01; 39(3):881-92. PubMed ID: 427777
    [Abstract] [Full Text] [Related]

  • 15. Immunomodulatory properties of recombinant murine and human tumor necrosis factor.
    Talmadge JE, Phillips H, Schneider M, Rowe T, Pennington R, Bowersox O, Lenz B.
    Cancer Res; 1988 Feb 01; 48(3):544-50. PubMed ID: 3257167
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Toxicity of intravesical recombinant human tumor necrosis factor in cynomolgus monkeys.
    Bahnson RR, Ballou BT, Ernstoff MS, Cramer DV, Schwentker FN, Reiland JM, Hakala TR.
    J Biol Response Mod; 1990 Aug 01; 9(4):445-7. PubMed ID: 2395009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.